Researchers identify molecular drivers of most common type of childhood brain tumour

22 Mar 2016, 6:32 p.m.

Two brain scans side by side

A team of researchers has identified the molecular drivers behind the most common type of paediatric brain tumour.The research, from teams working at Great Ormond Street Hospital, the UCL Institute of Child Health and four other research institutions could improve the treatment of children with a type of brain tumour known as pilocytic astrocytoma.

The researchers carried out tests on brain tumour samples taken from 57 children, detailing microRNA (mRNA) and gene expression profiles alongside a pathway analysis. The findings suggested that there is a distinctive mRNA and gene expression profile in pilocytic astrocytoma when compared to other paediatric brain tumours.

Researchers found mRNA to be up-regulated and it is suggested that the resulting effect on the ERK/MAPK pathway contributes to the unique phenotype of pilocytic astrocytoma.

Pilocytic astrocytomas are the most common type of central nervous tumours in children. They are often slow growing, cystic well-circumscribed tumours that are most commonly situated within the cerebellum, making the removal of the tumour possible. However, many children are left with significant chronic disabilities following treatment.

The Great Ormond Street BRC supported the study, which is published in Acta Neuropathologica Communications.

GOSH and Amazon Web Services collaborate to drive digital innovation across care, research and education

GOSH and AWS have signed a Strategic Collaboration Agreement, demonstrating a shared ambition to enhance clinical care, operations, research and education through digital advancements.

Moving from Code to Clinic: how GOSH and Roche are turning data into better care

Our 5-year partnership with Roche has brought together expertise in clinical care, AI and data science to help unlock insights from complex healthcare data in a safe and secure way. Watch our new animation to learn more about the journey from code to clin

World-first same-day metagenomics for children can detect hidden infections in intensive care

GOSH has successfully implemented a pioneering same-day respiratory metagenomics testing service for children in intensive care, helping clinicians identify infections more quickly and make better-informed treatment decision

GOSH families at the heart of major £6m project to improve support for children with complex needs

Children, young people and families from GOSH will help shape a major new research programme